High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease

An Lehouck(KU Leuven), Wim Janssens(KU Leuven), Brigitte Decallonne(KU Leuven), Femke Baeke(KU Leuven), Claudia Carremans(KU Leuven), Chantal Mathieu(KU Leuven), Jan Verhaegen(KU Leuven), Roger Bouillon(KU Leuven), Marc Decramer(KU Leuven), Johan Van Eldere(Centre for European Policy Studies)

Annals of Internal Medicine

January 17, 2012

10.7326/0003-4819-156-2-201201170-00004

Cited by 362

Related Papers

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

|BMJ|2017|2.1k

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

|Diabetes Care|2022|1.9k

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

|European Respiratory Journal|1995|1.6k

Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions

|Endocrine Reviews|2018|1.1k

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

|Diabetologia|2022|986